Amiodarone and atrial fibrillation.
London
Barry
B
D000638:Amiodarone / Q000008:administration & dosage*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology*; D016275:Atrial Function / Q000187:drug effects*; D001713:Biphenyl Compounds / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005260:Female; D006041:Goats; D006329:Heart Conduction System / Q000187:drug effects / Q000503:physiopathology*; D007275:Injections, Intravenous; D008297:Male; D010627:Phenethylamines / Q000008:administration & dosage; D026902:Potassium Channel Blockers / Q000008:administration & dosage; D013449:Sulfonamides / Q000008:administration & dosage; D013552:Swine
C501729:AVE 0118; D000889:Anti-Arrhythmia Agents; D001713:Biphenyl Compounds; D010627:Phenethylamines; D026902:Potassium Channel Blockers; D013449:Sulfonamides; D000638:Amiodarone; C063533:dofetilide